Issue
The undersigned hereby assign all rights, included but not limited to copyright, for this manuscript to CMB Association upon its submission for consideration to publication on Cellular and Molecular Biology. The rights assigned include, but are not limited to, the sole and exclusive rights to license, sell, subsequently assign, derive, distribute, display and reproduce this manuscript, in whole or in part, in any format, electronic or otherwise, including those in existence at the time this agreement was signed. The authors hereby warrant that they have not granted or assigned, and shall not grant or assign, the aforementioned rights to any other person, firm, organization, or other entity. All rights are automatically restored to authors if this manuscript is not accepted for publication.
The study of CD14+HLA-DR-/low myeloid-drived suppressor cell (MDSC) in peripheral blood of peripheral T-cell lymphoma patients and its biological function
Corresponding Author(s) : Y Song
yongpingsongzz@163.com
Cellular and Molecular Biology,
Vol. 63 No. 3: Issue 3
Abstract
Peripheral T-cell lymphoma is the generic term of a group of heterogeneous disease in non-Hodgkin's lymphoma. To investigate the quantity of CD14+HLA-DR-/low MDSC and T cell subsets in peripheral blood of peripheral T cell lymphoma (PTCL) patients, and explore the biological functions of CD14+HLA-DR-/low MDSC in peripheral T-cell lymphoma. Flow cytometry was used to determine CD14+HLA-DR-/low MDSC and T cell subsets in peripheral blood of 33 peripheral T-cell lymphoma patients and 23 healthy cases; CD3 +T cells, CD14+HLA-DR-/low MDSC cells and HLA-DR+ cells were selected with magnetic activated cell sorting; Biotin-labeled micro magnetic beads (CD2 / CD3 / CD28) were used to stimulate amplification of CD3 + T cells, which were co-cultured and analyzed by flow cytometry for the effect of different concentrations of CD14+HLA-DR-/low MDSC on the proliferative activity of autologous CD3+ T cells. 1. CD14+HLA-DR-/low cells / CD14+ monocytes and CD4+ CD25+regulatory T cells Treg /CD4+Tlymphocytes were 3.28% (0.40% -17.74%) and 8.81% (0.76% -78.11 %) respectively, higher than the healthy control group with statistically significant difference (P <0.05);. 2. CD4+CD25+ Treg /CD4+Tlymphocyte and CD14+HLA-DR-/CD14+ monocytes in nucleated cells of lymphoma patients were 8.81% (0.76%-78.11%) and 3.28% (0.40% -17.74%) respectively, which was in positive correlation (correlation coefficient r = 0.510), with statistically significant difference (P = 0.002); 3. When the ratio of CD14+HLA-DR-/low and T cells was 1: 1, the proliferation inhibition of MDSC on autologous T cell is the strongest; after adding nor-NOHA, an ARG1 inhibitor, proliferation of T cells was recovered to 75.09 ± 5.18 %, IDO inhibitor 1-MT made the proliferation rate of T cells recovered to 84.05 ± 2.93%, and the proliferation rate of T cells was recovered to 97.80 ± 2.20% after combination of the IDO inhibitor and ARG1 inhibitor. CD14+HLA-DR-/lowMDSC inhibit the proliferation of T lymphocytes, which may be related ARG1 and IDO.
Keywords
Myeloid-derived suppressor cells
Peripheral T-cell lymphoma
CD14 HLA-DR-/low cells.
Du, J., Sun, X., & Song, Y. (2017). The study of CD14+HLA-DR-/low myeloid-drived suppressor cell (MDSC) in peripheral blood of peripheral T-cell lymphoma patients and its biological function. Cellular and Molecular Biology, 63(3), 62–67. https://doi.org/10.14715/cmb/2017.63.3.12
Download Citation
Endnote/Zotero/Mendeley (RIS)BibTeX
